February 1, 2019 / 6:09 AM / 22 days ago

Japan's Takeda posts 28 pct rise in Q3 operating profit

TOKYO, Feb 1 (Reuters) - Takeda Pharmaceutical Co Ltd on Friday posted a 27.9 percent rise in third-quarter operating profit, supported by strong sales of its drugs for bowel disease and multiple myeloma.

Profit reached 112.5 billion yen ($1.03 billion) in October-December, Japan’s biggest drugmaker said in a stock exchange filing.

The company also maintained its full-year operating profit forecast at 268.9 billion yen. That compared with the 240.7 billion yen average of 10 analyst estimates compiled by Refinitiv.

Takeda completed a $59 billion deal to acquire peer Shire in January, joining the ranks of the world’s biggest 10 drugmakers by sales - and also becoming one of the world’s most indebted.

($1 = 108.8700 yen)

Reporting by Takashi Umekawa; Editing by Christopher Cushing

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below